Free Trial

TRxADE HEALTH Q3 2023 Earnings Report

TRxADE HEALTH logo
$7.58 -0.55 (-6.77%)
(As of 12/20/2024 ET)

TRxADE HEALTH Earnings Headlines

TRxADE Health (NASDAQ: MEDS)
Scienture Holdings, Inc. (SCNX)
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
See More TRxADE HEALTH Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like TRxADE HEALTH? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TRxADE HEALTH and other key companies, straight to your email.

About TRxADE HEALTH

TRxADE HEALTH (NASDAQ:MEDS) operates as a health services information technology (IT) company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement; and designs, develops, owns, and operates a business-to-business web-based marketplace. It also distributes prescription medication, medical devices, and over the counter medication to pharmacies and medical clinics; and offers pricing transparency, purchasing capabilities, and other value-added services, as well as telehealth services. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. was founded in 2010 and is headquartered in Lutz, Florida.

View TRxADE HEALTH Profile

More Earnings Resources from MarketBeat

Upcoming Earnings